Hedge Fund - Acuta Capital Partners
Eyepoint Pharmaceuticals Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $9,824,708 | 5.53% | 425,128 | $ |
| 2 | 2023 - Q3 (2023-09-30) | $2,398,023 | 1.6% | 300,128 | $ |
| 3 | 2023 - Q2 (2023-06-30) | $3,323,400 | 2.25% | 382,000 | $ |
| 4 | 2023 - Q1 (2023-03-31) | $891,984 | 0.65% | 303,396 | $ |
| 5 | 2022 - Q4 (2022-12-31) | $1,061,886 | 0.65% | 303,396 | $ |
| 6 | 2022 - Q3 (2022-09-30) | $2,400,000 | 1.03% | 303,396 | $ |
| 7 | 2022 - Q2 (2022-06-30) | $2,388,000 | 1.33% | 303,396 | $ |
| 8 | 2022 - Q1 (2022-03-31) | $3,742,000 | 1.74% | 307,944 | $ |
| 9 | 2021 - Q4 (2021-12-31) | $2,975,000 | 1.25% | 243,072 | $ |
| 10 | 2021 - Q3 (2021-09-30) | $3,854,000 | 1.35% | 369,863 | $ |
| 11 | 2021 - Q2 (2021-06-30) | $3,325,000 | 1.32% | 369,863 | $ |
| 12 | 2021 - Q1 (2021-03-31) | $3,872,000 | 1.39% | 381,145 | $ |
The displayed share prices are average quarterly stock market prices.